Publications by authors named "Elisabeth Trapp"

Claim this Profile
D
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
Elisabeth K Trapp, Peter A Fasching, Tanja Fehm, Andreas Schneeweiss, Volkmar Mueller

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Amelie de Gregorio, Wolfgang Janni, Thomas W P Friedl, Ulrike Nitz, Brigitte Rack, Elisabeth Trapp

Br J Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
Florian Fitzal, Michael Bolliger, Daniela Dunkler, Angelika Geroldinger, Luca Gambone, Elisabeth K Trapp

Ann Surg Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
Theresa Vilsmaier, Helene Hildegard Heidegger, Lennard Schröder, Elisabeth Trapp, Alaleh Zati Zehni

Arch Gynecol Obstet· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Di Cosimo, Torri, and Porcu.
Elisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, Julia Jückstock, Ulrich Andergassen

J Natl Cancer Inst· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Fabienne Schochter, Brigitte Rack, Marie Tzschaschel, Arkadius Polasik, Ulrich Andergassen, Elisabeth Trapp

Oncol Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
Elisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, Julia Jückstock, Ulrich Andergassen

J Natl Cancer Inst· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
Miriam Deniz, Amelie DeGregorio, Nikolaus DeGregorio, Inga Bekes, Peter Widschwendter, Elisabeth Trapp

Breast· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EpCAM and EpCAM circulating tumor cells in metastatic prostate and breast cancer patients.
Sanne de Wit, Mariangela Manicone, Elisabetta Rossi, Rita Lampignano, Liwen Yang, Elisabeth Katharina Trapp

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
Marianna Alunni-Fabbroni, Leonie Majunke, Elisabeth K Trapp, Marie Tzschaschel, Sven Mahner

BMC Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Elisabeth Katharina Trapp, Leonie Majunke, Beate Zill, Harald Sommer, Ulrich Andergassen

Mol Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer.
Amelie De Gregorio, Thomas W P Friedl, Jens Huober, Christoph Scholz, Nikolaus De Gregorio, Elisabeth Trapp

JCO Precis Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study.
Elisabeth Trapp, J Steidl, B Rack, M S Kupka, U Andergassen

Breast· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Amelie Schramm, Fabienne Schochter, Thomas W P Friedl, Nikolaus de Gregorio, Ulrich Andergassen, Elisabeth Trapp

Clin Breast Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Brigitte Rack, Julia Jückstock, Elisabeth Trapp, Tobias Weissenbacher, Marianna Alunni-Fabbroni

Tumour Biol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Philip Hepp, Ulrich Andergassen, Bernadette Jäger, Elisabeth Trapp, Marianna Alunni-Fabbroni

Anticancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Brigitte Rack, Ewa Zombirt, Elisabeth Trapp, Julia Jückstock, Ulrich Andergassen

Oncology· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.
Michail Ignatiadis, Brigitte Rack, Francoise Rothé, Sabine Riethdorf, Charles Decraene, Elisabeth Trapp

Eur J Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Julia Jueckstock, Brigitte Rack, Thomas W P Friedl, Christoph Scholz, Julia Steidl, Elisabeth Trapp

BMC Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
Alexander König, Theresa Vilsmaier, Brigitte Rack, Klaus Friese, Wolfgang Janni, Elisabeth Trapp

Anticancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Amelie Schramm, Thomas W P Friedl, Fabienne Schochter, Christoph Scholz, Nikolaus de Gregorio, Elisabeth Trapp

Arch Gynecol Obstet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
Peter Widschwendter, Thomas Wp Friedl, Lukas Schwentner, Nikolaus DeGregorio, Bernadette Jaeger, Elisabeth Trapp

Breast Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis